Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia
A high risk of gastrointestinal bleeding has been reported with the use of some direct oral anticoagulants (DOACs). This risk may be of particular concern in individuals with associated anaemia. The aim of this study is to investigate potential differences in the risks of gastrointestinal bleeding and stroke among the four available DOACs in patients with atrial fibrillation (AF) and moderate or severe anaemia.
Source: Thrombosis Research - Category: Hematology Authors: Nour Al-Hussainy, Kristian Hay Kragholm, S øren Lundbye-Christensen, Christian Torp-Pedersen, Manan Pareek, Susette Krohn Therkelsen, Gregory Y.H. Lip, Sam Riahi Tags: Full Length Article Source Type: research
More News: Anemia | Atrial Fibrillation | Bleeding | Gastroenterology | Hematology | Stroke | Study | Thrombosis